These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37086183)

  • 21. Efficacy and Safety of tranexamic acid versus vitamin c after microneedling in treatment of melasma: Clinical and Dermoscopic study.
    El Attar Y; Doghaim N; El Far N; El Hedody S; Hawwam SA
    J Cosmet Dermatol; 2022 Jul; 21(7):2817-2825. PubMed ID: 34699671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial.
    Badran AY; Ali AU; Gomaa AS
    Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in facial hyperpigmentation after treatment with a combination of topical niacinamide and tranexamic acid: a randomized, double-blind, vehicle-controlled trial.
    Lee DH; Oh IY; Koo KT; Suk JM; Jung SW; Park JO; Kim BJ; Choi YM
    Skin Res Technol; 2014 May; 20(2):208-12. PubMed ID: 24033822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An emerging technology in lipid research for targeting hydrophilic drugs to the skin in the treatment of hyperpigmentation disorders: kojic acid-solid lipid nanoparticles.
    Khezri K; Saeedi M; Morteza-Semnani K; Akbari J; Rostamkalaei SS
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):841-853. PubMed ID: 32456476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laser-assisted delivery of tranexamic acid for melasma: Pilot study using a novel 1927 nm fractional thulium fiber laser.
    Wang JV; Christman MP; Feng H; Ferzli G; Jeon H; Geronemus RG
    J Cosmet Dermatol; 2021 Jan; 20(1):105-109. PubMed ID: 33174686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma.
    Gamea MM; Kamal DA; Donia AA; Hegab DS
    J Dermatolog Treat; 2022 Mar; 33(2):798-804. PubMed ID: 32567984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral tranexamic acid lightens refractory melasma.
    Tan AWM; Sen P; Chua SH; Goh BK
    Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nano-Lipidic Carriers as a Tool for Drug Targeting to the Pilosebaceous Units.
    Ramkar S; Sah AK; Bhuwane N; Choudhary I; Hemnani N; Suresh PK
    Curr Pharm Des; 2020; 26(27):3251-3268. PubMed ID: 32410556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of tranexamic acid in the treatment of adult melasma: An updated meta-analysis of randomized controlled trials.
    Feng X; Su H; Xie J
    J Clin Pharm Ther; 2021 Oct; 46(5):1263-1273. PubMed ID: 33959984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different therapeutic approaches in melasma: advances and limitations.
    Ghasemiyeh P; Fazlinejad R; Kiafar MR; Rasekh S; Mokhtarzadegan M; Mohammadi-Samani S
    Front Pharmacol; 2024; 15():1337282. PubMed ID: 38628650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New topical tranexamic acid derivative for the improvement of hyperpigmentation and inflammation in the sun-damaged skin.
    da Silva Souza ID; Lampe L; Winn D
    J Cosmet Dermatol; 2021 Feb; 20(2):561-565. PubMed ID: 32588531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laser-Assisted Drug Delivery of Tranexamic Acid by Picosecond Laser in Postinflammatory Hyperpigmentation: A Split-Area Double Blind Randomized Prospective Study.
    Lin CH; Tsai YJ; Lin KC; Hsieh MH; Lin HP; Hsu SY; Tsai HH; Hsieh CH
    Photobiomodul Photomed Laser Surg; 2021 Nov; 39(11):711-715. PubMed ID: 34762534
    [No Abstract]   [Full Text] [Related]  

  • 34. Whitening effect of kojic acid dipalmitate loaded nanosized ethosomal gel for the treatment of hyperpigmentation: In vitro and in vivo characterization.
    Tanveer N; Khan HMS; Akhtar N
    J Cosmet Dermatol; 2022 Dec; 21(12):6850-6862. PubMed ID: 36156360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of topical 5% tranexamic acid at pH 2.38 with and without corundum microdermabrasion on pigmentation and skin surface lipids.
    Batory M; Wołowiec-Korecka E; Rotsztejn H
    Dermatol Ther; 2020 Nov; 33(6):e14391. PubMed ID: 33034937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of combined fractional CO
    Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
    Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis.
    Shrotriya S; Ranpise N; Satpute P; Vidhate B
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1471-1482. PubMed ID: 28884598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-hydroxycoumarin loaded vesicles for recombinant human tyrosinase inhibition in topical applications.
    Schlich M; Fornasier M; Nieddu M; Sinico C; Murgia S; Rescigno A
    Colloids Surf B Biointerfaces; 2018 Nov; 171():675-681. PubMed ID: 30107341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized, double-blind, placebo-controlled split-face trial of the efficacy of tranexamic acid by drug delivery through microneedling in the treatment of melasma.
    Kuster Kaminski Arida D; Orso Rebellato PR; Marioto de Campos GL; Costa A; Vilaverde Schmitt J; Larocca Skare T; Rodrigues Lisboa Faucz L
    J Cosmet Dermatol; 2021 Dec; 20(12):4005-4010. PubMed ID: 34077619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances and development in epidermal and dermal drug deposition enhancement technology.
    Iqbal B; Ali J; Baboota S
    Int J Dermatol; 2018 Jun; 57(6):646-660. PubMed ID: 29430629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.